MedMen Enterprises Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Melony Valleau CPA
- Full Time Employees
- 428
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 10115 Jefferson Boulevard Culver City CA United States of America 90232
- IPO Date
- May 30, 2018
- CIK
- 0001776932
- Website
- medmen.com
- Similar Companies
- Business
- MedMen Enterprises Inc. (MMNFF) operates as a cannabis retailer focused on cultivation, manufacturing, and retail sales of recreational and medicinal cannabis products in California. The company offers premium flower, pre-rolls, vapes, effects-based gummies, edibles, concentrates, tinctures, and CBD wellness items sourced from top brands and boutique cultivators; its proprietary brands include MedMen Red and LuxLyte; services encompass in-store shopping, online ordering, curbside pickup, and discreet delivery available 365 days a year. MedMen maintains three dispensaries in key California locations—Downtown Los Angeles, West Hollywood, and near LAX Airport—targeting medical and recreational consumers with an extensive selection exceeding 400 products emphasizing quality, safety, and customer education. Founded in 2010 by Adam Bierman and Andrew Modlin and headquartered in Culver City, California, MedMen previously expanded aggressively across states including Nevada, Arizona, Florida, Illinois, New York, and Massachusetts, operating up to 32 dispensaries and multiple cultivation facilities at its peak. In recent major changes, MedMen filed for bankruptcy proceedings in Canada in April 2024 with approximately $411 million in liabilities, while its U.S. subsidiary entered Chapter 7 liquidation and receivership in Los Angeles Superior Court, leading to the permanent discontinuation of most operations and closure of stores outside select California sites; the Canadian Securities Exchange suspended trading in January 2024 and delisted the stock in May 2024; earlier exits included sales of Arizona and Nevada operations to competitors like MINT Cannabis.
CSE Bulletin: Delist - MedMen Enterprises Inc. (MMEN)
Cannabis firm MedMen enters bankruptcy proceedings in Canada, receivership in US
Cannabis firm MedMen enters bankruptcy proceedings in Canada, receivership in US
Cannabis company MedMen files for bankruptcy with about $411M in liabilities as it fortunes go up in smoke
MedMen Announces Entering Bankruptcy Proceedings and Resignation of CFO and Directors
Exit Now! 3 Cannabis Stocks to Sell in February 2024
MedMen Announces Management and Board Changes
MedMen goes from height of $3B valuation to zero as stock draws cease-trade order
MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis
MedMen Provides Annual Filing Status Report
MedMen Enters into Definitive Agreements to Exit Arizona and Nevada per Announced Strategic Review, Selling Non-Core Assets to MINT Cannabis
MedMen Provides Annual Filing Status Report
MedMen Provides Annual Filing Status Report
Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now.
MedMen Announces Delay of Filing of Financial Statements for the Year Ended July 1, 2023 and Issuance of Management Cease Trade Order
Reasons To Be Cautiously Optimistic About Cannabis
Ticking Time Bombs: 3 Cannabis Stocks to Dump Before the Damage Is Done
The Sustainability Of Cannabis Bull Run
Year-to-Date Winners: Top Marijuana Penny Stocks to Keep on Your Radar
Top Marijuana Penny Stocks to Watch in August 2023